News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication May 14, 2019 Definitions of Response and Remission for the Robarts Histopathology Index Brian Feagan, Geert D’Haens, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 Standardising the Interpretation of Liver Biopsies in Non-alcoholic Fatty Liver Disease Clinical Trials Brian Feagan, Vipul Jairath Read Now
Publication May 14, 2019 Early Combined Immunosuppression May Be Effective and Safe in Older Patients With Crohn’s Disease: Post Hoc Analysis of REACT Brian Feagan, Guangyong Zou, Vipul Jairath Read Now
Publication May 14, 2019 Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis Brian Feagan, Niels Vande Casteele, Vipul Jairath Read Now
Publication Oct 18, 2018 A Composite Disease Activity Index for Early Drug Development in Ulcerative Colitis: Development and Validation of the UC-100 Score Brian Feagan, Geert D’Haens, Guangyong Zou, Vipul Jairath Read Now
Publication Sep 15, 2018 Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions Brian Feagan, Guangyong Zou Read Now
